Psoriatic arthritis (PsA) increases the disease burden associated with psoriasis by further
diminishing quality of life, increasing health care costs and cardiovascular risk, and …

Psoriatic arthritis (PsA) affects up to one-third of patients with psoriasis. It is the major
comorbidity of psoriasis because of the likelihood that loss of function and permanent …

Psoriatic arthritis (PsA) is a chronic, systemic inflammatory disease. Up to 40% of patients
with psoriasis will go on to develop PsA, usually within 5–10 years of cutaneous disease …

Psoriasis and psoriatic arthritis (PsA) are chronic immune-mediated diseases that primarily
affect the skin and joints, respectively; these diseases are also associated with high rates of …

Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. It is
found in approximately 10% of psoriatic patients in Japan. PsA mainly affects the peripheral …

Psoriatic arthritis (PsA) has been defined as a unique inflammatory arthritis associated with
psoriasis. Its exact prevalence is unknown, but estimates vary from 0.3% to 1% of the …

Psoriatic arthritis (PsA) is a unique type of i nflammatory arthritis that is associated with skin
psoriasis. The concept that PsA is simply a skin and joint disease has been challenged by …

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to
decreased health-related quality of life and permanent joint damage leading to functional …

Clinicians often view psoriatic arthritis (PsA) as a rather minor arthritic disorder because
many are unaware of the substantial damage, disability, and reduced quality of life that …

Psoriatic arthritis (PsA) accounts for around 20% of referrals to the early arthritis clinic and
presents a significant diagnostic and management challenge. Early diagnosis is important to …